EU approved Avastin®

DRUG3 trials

Sponsors

mAbxience Research S.L.

Conditions

Healthy VolunteersJapaneseMale

Phase 1

A Pharmacokinetic Study Comparing MB02 And US And EU Avastin® In Healthy Male Volunteers

CompletedNCT03293654

mAbxience Research S.L.Healthy Volunteers

Start: 2017-12-07End: 2019-05-29Updated: 2021-03-23

A Pharmacokinetic Study Comparing MB02 And EU Avastin® In Healthy Male Volunteers

CompletedNCT04238650

mAbxience Research S.L.Healthy Volunteers, Japanese, Male

Start: 2019-08-02End: 2019-12-27Updated: 2021-03-23

Pharmacokinetic Study Comparing MB02 And US And EU Avastin® In Healthy Male Volunteers

CompletedNCT04238663

mAbxience Research S.L.Healthy Volunteers

Start: 2019-09-24End: 2020-03-17Updated: 2023-10-25

Related Papers

A randomized, double blind, single dose, comparative study of the pharmacokinetics, safety and immunogenicity of MB02 (bevacizumab biosimilar) and reference bevacizumab in healthy male volunteers.

2021-09-0410 citations

A randomized, single-dose, pharmacokinetic equivalence study comparing MB02 (proposed biosimilar) and reference bevacizumab in healthy Japanese male volunteers.

2021-07-169 citations

Efficacy, Safety and Immunogenicity of MB02 (Bevacizumab Biosimilar) versus Reference Bevacizumab in Advanced Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Phase III Study (STELLA).

2021-04-2923 citations